FDA Inspection
QPS, LLCQPS, LLC – FDA Inspection, Dec 16, 2016
Record Details
This FDA Inspection record concerns QPS, LLC, with an inspection on December 16, 2016, issued by the Philadelphia District Office, covering human drugs.
- People
- Mohsen Rajabi Abhari (Issuing Officer)
- Nicola M. Fenty-Stewart (Issuing Officer)
View Company Profile
ID · 5ab60e97-d434-4592-8660-9a4bf6de585e
Inspection Facts
- Inspection number
- 1022437
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of QPS, LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2026 | Not classified | Philadelphia District Office | |
| September 26, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 16, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 8, 2017 | Not classified | Philadelphia District Office | |
| August 25, 2017 | Not classified | Philadelphia District Office |
Other documents for QPS, LLC
- FDA Inspection 1309174 - 2026-01-30
- FDA Inspection 1252806 - 2024-09-26
- FDA Inspection 1079523 - 2019-01-16
- FDA Inspection 1037769 - 2017-12-08
- FDA Inspection 1026017 - 2017-08-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.